|
| |
| | 58073 | | 06.02.2008 | | Takeda Pharma AG | | | | | | | | | | | | 07.99. | | | | 07.99. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Fosrenol 250 mg | Kautabletten | Chewing tablets () | V03AE03 | CI | 02 | Fosrenol 500 mg | Kautabletten | Chewing tablets (Lanthanum 500 mg ut Lanthani(Iii) Carbonas Hydricum 954 mg) | V03AE03 | CI | 03 | Fosrenol 750 mg | Kautabletten | Chewing tablets (Lanthanum 750 mg ut Lanthani(Iii) Carbonas Hydricum 1431 mg) | V03AE03 | CI | 04 | Fosrenol 1000 mg | Kautabletten | Chewing tablets (Lanthanum 1000 mg ut Lanthani(Iii) Carbonas Hydricum 1908 mg) | V03AE03 | CI |
|
|
|